Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.

A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.

At the pediatric dermatology clinic a few days later, physical examination revealed a slightly erythematous macule on the ...

Psoriasis frequently appears on the arms, often on your elbow. Several types of psoriasis may affect your arms, but plaque psoriasis is the most common. The earliest sign may be a small bump, but the ...

Featured pricing is subject to change. There is nothing fun about flakes falling from your scalp — luckily one of the best dandruff shampoos can help. First things first: what is dandruff?

Medically reviewed by Susan Bard, MD Understanding the difference between dandruff and dry scalp, two conditions that can cause a flaky scalp, can help you determine how to treat it. A dry scalp is ...

Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

Glowing customer review: “After I had my second baby, my scalp became sensitive and had severe dandruff. No matter how many times I would wash my hair, it wouldn’t help. This worked amazingly.

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a pair of phase 3 trials. The Protagonist Therapeutics-partnered IL-23 ...

Moderate to severe scalp psoriasis severely affects quality of life, with high DLQI scores and significant symptoms like itch, pain, and flaking. Deucravacitinib, a tyrosine kinase 2 inhibitor ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

and local tolerability data in scalp and body psoriasis In the United States, AD affects approximately 26 million adults and children and psoriasis affects approximately 9 million adults and ...